Long-term studies on hydroxyurea use in children with sickle cell disease
. | Reference 6 . | Reference7 . | Reference 8 . |
---|---|---|---|
No. patients at inclusion | 84 | 101 | 93 |
Mean age at inclusion (y) | 9.8 ± 3.2 | 9.8 ± 0.4 | 7 |
No. patients after 2 y | 35 | 45 | 61 |
No. patients after 3 y | ND | 36 | 44 |
Malignancy | 0 | 1, not related to HU | 0 |
. | Reference 6 . | Reference7 . | Reference 8 . |
---|---|---|---|
No. patients at inclusion | 84 | 101 | 93 |
Mean age at inclusion (y) | 9.8 ± 3.2 | 9.8 ± 0.4 | 7 |
No. patients after 2 y | 35 | 45 | 61 |
No. patients after 3 y | ND | 36 | 44 |
Malignancy | 0 | 1, not related to HU | 0 |
ND indicates not determined.